Global OTC Analgesics Market Outlook with Ongoing Trends, Top Players Profile Analysis and Forecast 2017-2022

A freshly compiled business intelligent report, titled “OTC Analgesics Market Research Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been publicized to the vast archive of Fact.MR online repository. This 170 page study delivers all the vital details and information required to know about OTC analgesics market current as well as future prospects. The analysts of the study have gone through extensive research methodologies in order to generate data and information that reflects the latest market undercurrents and industry trends. For a deeper understanding of the market, a sub-category level analysis has been elaborated, by which readers and investors of the report will able to know that where the market stands to gain.

Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=75

Pharmacy to Remain the Most Lucrative OTC Channel in the Global OTC Analgesics Market

Pharmacy will remain the most lucrative OTC channel for sales of OTC analgesics in the market. Drug store is expected to be the second largest OTC channel in the market. OTC analgesics sales in online store, and the modern trade OTC channels will register the fastest expansion through 2022.

North America will continue to account for the largest revenue share of the market, and is estimated to retain its dominance in the global OTC analgesics market over the forecast period. In addition, Europe will remain the second most lucrative market for OTC analgesics, however the market in Japan will register a relatively faster expansion than in Europe through 2022.

OTC analgesics in the form of tablets will account for more than half revenue share of the market over the forecast period. In addition, tablet OTC analgesics are anticipated to remain sought-after among consumers around the world. Capsule will continue to be the second largest sold OTC analgesics product in the global market, with sales expanding at the highest CAGR throughout the forecast period.

Competition Tracking

Key market players mentioned in Fact.MR’s report include Sun Pharmaceuticals Industries Limited, Johnson & Johnson Service, Inc., AstraZeneca Plc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., and Pfizer Inc.

Browse Full Report with TOC@ https://www.factmr.com/report/75/otc-analgesics-market

Table of Contents:

Global OTC Analgesics Market – Executive Summary
Global OTC Analgesics Market Overview
2.1. Introduction
2.1.1. Global OTC Analgesics Market Taxonomy
2.1.2. Global OTC Analgesics Market Definition
2.2. Global OTC Analgesics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global OTC Analgesics Market Y-o-Y Growth
2.3. Global OTC Analgesics Market Dynamics
2.3.1. Drivers
2.3.2. Restraints
2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. List of Distributors
2.7. Average Pricing Analysis
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region
Global OTC Analgesics Market Analysis and Forecast By OTC Channel
3.1. Global OTC Analgesics Market Size and Forecast By OTC Channel, 2012-2022
3.1.1. Pharmacy OTC Analgesics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
Continued………

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=75

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.